Search

everythinglearnresearchcommunity

for

Search:↓

Hirsutism severity is linked to androgen levels, especially in women with a lower LH/FSH ratio.

Alternative treatments show promise for hair growth beyond traditional methods.

Women with conditions like PCOS may have a higher risk of COVID-19, but treatments like isotretinoin could help those with acne.

Testosterone and dihydrotestosterone affect hair growth, and new techniques like the folliculogram help study it, but fully understanding hair growth is still complex.

Estradiol-rich plasma can increase hair density faster and more effectively in male pattern baldness treatment than regular plasma.

The document concludes that while lab results for hair growth promotion are promising, human trials are needed and better testing methods should be developed.

Low iron levels are linked to more hair loss in non-menopausal women.

PRP therapy may increase hair density in pattern hair loss without serious side effects, but more research is needed.

Testosterone can both promote hair growth and cause baldness by affecting hair growth signals.

Hair loss may signal metabolic problems and increased risk of heart disease, suggesting people with hair loss should be checked for these issues.

Lower vitamin D levels are linked to more severe hair loss in men.

White hirsute women with PCOS have higher insulin resistance, but similar nitric oxide and fibrinogen levels compared to those with idiopathic hirsutism.

Protease Nexin-1 is found in human hair growth cells and is affected by male hormones.

Smoking and drinking can lower vitamin levels and potentially trigger early hair loss, but overall vitamin levels don't seem to affect hair loss duration.

LLLT is a safe, promising hair loss treatment, but more research needed.

High levels of prolactin in the blood can be linked to widespread hair loss.

Purple sweet potato leaf extracts can help treat hair loss and fungal infections.

The 2004 hair research meeting presented new findings on hair cell differentiation, genetic factors in hair loss, hair pigmentation, and potential targeted therapies.

Trichoriboside treatment helps maintain scalp hair by increasing cAMP levels in hair follicles of men with hair loss.

Androgens play a key role in hair growth.

LLLT increases hair density and growth in AGA patients.

Women's hair gets thinner and grayer as they age, with treatments available for hair loss and graying.

Steroids, particularly estrogens and 5α-reductase inhibitors, affect blood vessel-related hair growth processes in hair follicle cells.

Female pattern hair loss involves thinning hair on crown and frontal scalp, diagnosed by hair ratio, and treated with minoxidil, antiandrogens, or hair transplantation.

Different hair and scalp disorders cause hair loss or excess hair growth, with various treatments available depending on the specific condition.

Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Hair loss occurs due to fewer papillary cells, smaller follicles, and shorter growth phases.

Lowering testosterone speeds up wound healing in male mice.

Topical drugs and near-infrared light therapy show potential for treating alopecia.